The scope of the trial is to predict the early complete clinical response to exclusive
concomitant radiochemotherapy in esophageal cancer by the study of the pre- and per-
therapeutic proteomic profile.
Procedure: Blood sampling
Drug: Chemotherapy (Fluorouracil and Cisplatin)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT00911092
Ages eligible for Study
18 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Invasive esophageal carcinoma at any stage (all T, N0 or N1, M0 or M1a), histologically proven
Treated by exclusive concomitant radiochemotherapy